CME 17.4.23

Secondary complication condition that develops in the course of a disease which the patient has.

• YES

• NO

ASPIRIN IS BENEFICIAL FOR A PATIENT WITH DM WITH NO IHD.

• YES

• NO

Answer explanation

Patients without known atherosclerotic disease who are at risk of cardiovascular disease, the overall benefits of aspirin in terms of primary prevention of atherothrombotic events do not outweigh the risk in terms of bleeding

INTRINSIC RESISTANCE OF AN ANTIBIOTIC DEPENDS ON THE MOA OF THE ANTIBIOTIC ITSELF

• YES

• NO

ENTEROBACTER CLOACEA SP. INTRINSICALLY RESISTANCE TO

• AMPICILLIN

• AMOXICILLIN/CLAVULANATE

• PIPERACILLIN/TAZOBACTAM

• CEFOXITIN

SAVE CIPROFLOXACIN FOR CASES LIKE

• PSEUDOMONAS

• KLEBSIELLA PNEUMONIA

• NON-TYPICAL THYPHOID